Gut health boost: synbiotics show promise for diabetes management
NCT ID NCT04552002
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether taking a synbiotic (a mix of probiotics and prebiotics) for 6 months could improve blood sugar control, reduce inflammation, and change body composition in adults with prediabetes or type 2 diabetes. Researchers recruited 64 participants from a hospital in Saudi Arabia and measured markers like HbA1c, inflammatory proteins, and body fat. The goal was to see if this simple dietary supplement could support diabetes management by targeting the gut microbiome.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
synbiotic (probiotics and prebiotics)
What this could lead to
If it works, this could point toward a simple dietary supplement to help manage blood sugar and inflammation in people with prediabetes or type 2 diabetes.
What could go wrong
This is a small, completed Phase 3 trial with only 64 participants, so results may not apply to everyone. Dietary supplements often show modest effects, and the study did not test long-term outcomes or safety beyond 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Family Medicince Community Centre
Dammam, Eastern Province, Saudi Arabia
-
King Fahd University Hospital
Dammam, Eastern Province, Saudi Arabia